CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
67 hedge funds and large institutions have $58M invested in Cascadian Therapeutics, Inc. in 2013 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
8% less capital invested
Capital invested by funds: $62.8M → $58M (-$4.81M)
Holders
67
Holding in Top 10
1
Calls
$2.36M
Puts
$767K
Top Buyers
| 1 | +$3.24M | |
| 2 | +$3.15M | |
| 3 | +$934K | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$814K |
| 5 |
First Eagle Investment Management
New York
|
+$615K |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$1.22M | |
| 3 | -$1.03M | |
| 4 |
Renaissance Technologies
New York
|
-$970K |
| 5 |
Goldman Sachs
New York
|
-$413K |